The Shift Towards Platform Technologies in Oncology: Why 60% of Pharma Pipelines Are Changing As smart investments sharply shift towards platform-based therapies in oncology, discover how this trend is redefining pharmaceutical pipelines and clinical advancements.

The Shift Towards Platform Technologies in Oncology: Why 60% of Pharma Pipelines Are Changing #USA #Vancouver #ADC_Therapeutics #GT_Biopharma #Sutro_Biopharma